ctrl K

Price Alert

RAPT Therapeutics Inc. (RAPT)

NASDAQ: RAPT · Real-Time Price · USD

11.79

0.54 (4.80%)

At close: Aug 15, 2025, 3:59 PM

11.65

-1.18%

After-hours: Aug 15, 2025, 06:13 PM EDT

RAPT Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	169.74M	47.48M	38.95M	24.03M
Short-Term Investments	61.32M	111.38M	210.12M	165.63M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	389K	3.87M	4.04M	2.92M
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	4.18M	2.92M	3.63M	3.32M
Total Current Assets	235.24M	161.78M	252.69M	192.97M
Property-Plant & Equipment	4.7M	7.68M	9.48M	2.74M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	5.09M	11.55M	13.52M	5.66M
Total Assets	240.32M	173.33M	266.21M	198.64M
Account Payables	1.27M	5.18M	3.37M	2M
Deferred Revenue	n/a	n/a	n/a	1.02M
Short-Term Debt	2.42M	n/a	2.17M	n/a
Other Current Liabilities	9.65M	7.91M	2.48M	2.93M
Total Current Liabilities	48.35M	21.84M	14.22M	9.6M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	2.15M
Total Long-Term Liabilities	2.07M	4.46M	6.82M	2.66M
Total Liabilities	50.42M	26.29M	21.04M	12.26M
Total Debt	4.49M	6.91M	8.99M	n/a
Common Stock	13K	3K	3K	3K
Retained Earnings	-614.55M	-484.68M	-367.88M	-284.05M
Comprehensive Income	50K	103K	-26K	-206K
Shareholders Equity	189.9M	147.03M	245.17M	186.38M
Total Investments	61.32M	111.38M	210.12M	165.63M